ISSN 1662-4009 (online)

ey0017.15-4 | (1) | ESPEYB17

15.4. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis

JL Tarry-Adkins , CE Aiken , SE Ozanne

To read the full abstract: PLoS Med. 2019 Aug 6;16(8):e1002848. doi: 10.1371/journal.pmed.1002848.This systematic review identified 28 randomised trials (n =3976 women) of metformin vs. insulin for treatment for gestational diabetes. Metformin use was associated with lower birth weights (overall mean difference −107.7 g), lower ponderal indices, and lower odds of macros...

ey0017.2-18 | Maternal Obesity and Long-Term Infant Consequences | ESPEYB17

2.18. Exposure to maternal obesity programs sex differences in pancreatic islets of the offspring in mice

LM Nicholas , M Nagao , LC Kusinski , DS Fernandez-Twinn , L Eliasson , SE Ozanne

To read the full abstract: Diabetologia. 2020 Feb;63(2):324–337. PMID:31773193Maternal obesity is a risk factor for the development of type 2 diabetes in the offspring. Exposure to maternal obesity alters pancreatic islet structure and function, including reduced beta-cell mass and impaired glucose stimulated insulin secretion, which both increase susceptibility to type 2 diab...